论文信息 - Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy with Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong - 字舞流文

Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy with Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong

S. Chandwani | J. Pellissier | Carlos K. H. Wong | D. C. Hsu | H. Loong | R. Insinga | Mary Y. K. Lee | S. Tan | Praveen Dhankhar | L. Leung | Min Huang | A. Rai | M. Achra